Literature DB >> 29263256

Cryo-Electron Microscopy Structure of Seneca Valley Virus Procapsid.

Mike Strauss1, Nadishka Jayawardena2, Eileen Sun1, Richard A Easingwood3, Laura N Burga4, Mihnea Bostina4,3.   

Abstract

Seneca Valley virus (SVV), like some other members of the Picornaviridae, forms naturally occurring empty capsids, known as procapsids. Procapsids have the same antigenicity as full virions, so they present an interesting possibility for the formation of stable virus-like particles. Interestingly, although SVV is a livestock pathogen, it has also been found to preferentially infect tumor cells and is being explored for use as a therapeutic agent in the treatment of small-cell lung cancers. Here we used cryo-electron microscopy to investigate the procapsid structure and describe the transition of capsid protein VP0 to the cleaved forms of VP4 and VP2. We show that the SVV receptor binds the procapsid, as evidence of its native antigenicity. In comparing the procapsid structure to that of the full virion, we also show that a cage of RNA serves to stabilize the inside surface of the virus, thereby making it more acid stable.IMPORTANCE Viruses are extensively studied to help us understand infection and disease. One of the by-products of some virus infections are the naturally occurring empty virus capsids (containing no genome), termed procapsids, whose function remains unclear. Here we investigate the structure and formation of the procapsids of Seneca Valley virus, to better understand how they form, what causes them to form, how they behave, and how we can make use of them. One potential benefit of this work is the modification of the procapsid to develop it for targeted in vivo delivery of therapeutics or to make a stable vaccine against SVV, which could be of great interest to the agricultural industry.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Seneca Valley virus; cryo-electron microscopy; picornavirus; procapsid

Mesh:

Substances:

Year:  2018        PMID: 29263256      PMCID: PMC5827394          DOI: 10.1128/JVI.01927-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  64 in total

1.  Accurate determination of local defocus and specimen tilt in electron microscopy.

Authors:  Joseph A Mindell; Nikolaus Grigorieff
Journal:  J Struct Biol       Date:  2003-06       Impact factor: 2.867

2.  Asymmetric cryo-EM structure of the canonical Allolevivirus Qβ reveals a single maturation protein and the genomic ssRNA in situ.

Authors:  Karl V Gorzelnik; Zhicheng Cui; Catrina A Reed; Joanita Jakana; Ry Young; Junjie Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-26       Impact factor: 11.205

3.  Cryo-electron Microscopy Structures of Expanded Poliovirus with VHHs Sample the Conformational Repertoire of the Expanded State.

Authors:  Mike Strauss; Lise Schotte; Krishanthi S Karunatilaka; David J Filman; James M Hogle
Journal:  J Virol       Date:  2017-01-18       Impact factor: 5.103

4.  Initial testing of the replication competent Seneca Valley virus (NTX-010) by the pediatric preclinical testing program.

Authors:  Christopher L Morton; Peter J Houghton; E Anders Kolb; Richard Gorlick; C Patrick Reynolds; Min H Kang; John M Maris; Stephen T Keir; Jianrong Wu; Malcolm A Smith
Journal:  Pediatr Blood Cancer       Date:  2010-08       Impact factor: 3.167

5.  Human rhinovirus type 2 is internalized by clathrin-mediated endocytosis.

Authors:  Luc Snyers; Hannes Zwickl; Dieter Blaas
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

6.  Phase I trial of Seneca Valley Virus (NTX-010) in children with relapsed/refractory solid tumors: a report of the Children's Oncology Group.

Authors:  Michael J Burke; Charlotte Ahern; Brenda J Weigel; John T Poirier; Charles M Rudin; Yingbei Chen; Timothy P Cripe; M Brooke Bernhardt; Susan M Blaney
Journal:  Pediatr Blood Cancer       Date:  2014-10-12       Impact factor: 3.167

7.  Intravenous injection of oncolytic picornavirus SVV-001 prolongs animal survival in a panel of primary tumor-based orthotopic xenograft mouse models of pediatric glioma.

Authors:  Zhigang Liu; Xiumei Zhao; Hua Mao; Patricia A Baxter; Yulun Huang; Litian Yu; Lalita Wadhwa; Jack M Su; Adekunle Adesina; Lazlo Perlaky; Mary Hurwitz; Neeraja Idamakanti; Seshidhar Reddy Police; Paul L Hallenbeck; Richard L Hurwitz; Ching C Lau; Murali Chintagumpala; Susan M Blaney; Xiao-Nan Li
Journal:  Neuro Oncol       Date:  2013-05-07       Impact factor: 12.300

Review 8.  Review: Oncolytic virotherapy, updates and future directions.

Authors:  Christos Fountzilas; Sukeshi Patel; Devalingam Mahalingam
Journal:  Oncotarget       Date:  2017-05-31

9.  Structure of human Aichi virus and implications for receptor binding.

Authors:  Ling Zhu; Xiangxi Wang; Jingshan Ren; Abhay Kotecha; Thomas S Walter; Shuai Yuan; Teruo Yamashita; Tobias J Tuthill; Elizabeth E Fry; Zihe Rao; David I Stuart
Journal:  Nat Microbiol       Date:  2016-09-05       Impact factor: 17.745

10.  RELION: implementation of a Bayesian approach to cryo-EM structure determination.

Authors:  Sjors H W Scheres
Journal:  J Struct Biol       Date:  2012-09-19       Impact factor: 2.867

View more
  10 in total

1.  Seneca Valley virus attachment and uncoating mediated by its receptor anthrax toxin receptor 1.

Authors:  Lin Cao; Ran Zhang; Tingting Liu; Zixian Sun; Mingxu Hu; Yuna Sun; Lingpeng Cheng; Yu Guo; Sheng Fu; Junjie Hu; Xiangmin Li; Chengqi Yu; Hanyang Wang; Huanchun Chen; Xueming Li; Elizabeth E Fry; David I Stuart; Ping Qian; Zhiyong Lou; Zihe Rao
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-04       Impact factor: 11.205

2.  N-Linked Glycosylation on Anthrax Toxin Receptor 1 Is Essential for Seneca Valley Virus Infection.

Authors:  Nadishka Jayawardena; Linde A Miles; Laura N Burga; Charles Rudin; Matthias Wolf; John T Poirier; Mihnea Bostina
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

Review 3.  Seneca Valley Virus Exploits TEM8, a Collagen Receptor Implicated in Tumor Growth.

Authors:  David J Evans; Alexa M Wasinger; Robert N Brey; James M Dunleavey; Brad St Croix; James G Bann
Journal:  Front Oncol       Date:  2018-11-06       Impact factor: 6.244

4.  Potent Protective Immune Responses to Senecavirus Induced by Virus-Like Particle Vaccine in Pigs.

Authors:  Suyu Mu; Shiqi Sun; Hu Dong; Manyuan Bai; Yun Zhang; Zhidong Teng; Mei Ren; Shuanghui Yin; Huichen Guo
Journal:  Vaccines (Basel)       Date:  2020-09-15

5.  Identification of a conserved neutralizing epitope in Seneca Valley virus VP2 protein: new insight for epitope vaccine designment.

Authors:  Wei Wen; Xinghua Chen; Qiang Lv; Huanchun Chen; Ping Qian; Xiangmin Li
Journal:  Virol J       Date:  2022-04-11       Impact factor: 4.099

6.  The 5'-end motif of Senecavirus A cDNA clone is genetically modified in 36 different ways for uncovering profiles of virus recovery.

Authors:  Hailan Meng; Qi Wang; Meiling Liu; Ziwei Li; Xiaojing Hao; Di Zhao; Yaqin Dong; Shuang Liu; Feng Zhang; Jin Cui; Bo Ni; Hu Shan; Fuxiao Liu
Journal:  Front Microbiol       Date:  2022-08-17       Impact factor: 6.064

7.  Comparative Evaluation of the Foot-and-Mouth Disease Virus Permissive LF-BK αVβ6 Cell Line for Senecavirus A Research.

Authors:  Jessica Mason; Victoria Primavera; Lauren Martignette; Benjamin Clark; Jose Barrera; Janine Simmons; William Hurtle; John G Neilan; Michael Puckette
Journal:  Viruses       Date:  2022-08-25       Impact factor: 5.818

8.  Structural basis for anthrax toxin receptor 1 recognition by Seneca Valley Virus.

Authors:  Nadishka Jayawardena; Laura N Burga; Richard A Easingwood; Yoshimasa Takizawa; Matthias Wolf; Mihnea Bostina
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-31       Impact factor: 11.205

Review 9.  Virus-Receptor Interactions: Structural Insights For Oncolytic Virus Development.

Authors:  Nadishka Jayawardena; Laura N Burga; John T Poirier; Mihnea Bostina
Journal:  Oncolytic Virother       Date:  2019-10-29

10.  Construction of eGFP-Tagged Senecavirus A for Facilitating Virus Neutralization Test and Antiviral Assay.

Authors:  Fuxiao Liu; Yilan Huang; Qianqian Wang; Hu Shan
Journal:  Viruses       Date:  2020-03-05       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.